Presidio Achieves 2022 Dell Technologies Titanium Black Status
Partnership aims to accelerate digital transformation NEW YORK–(BUSINESS WIRE)–Presidio, Inc., a global digital services and…
Partnership aims to accelerate digital transformation NEW YORK–(BUSINESS WIRE)–Presidio, Inc., a global digital services and…
DUBLIN–(BUSINESS WIRE)–The “US DoD Unmanned Aerial Vehicles Growth Opportunities” report has been added to ResearchAndMarkets.com’s…
BOSTON, March 25, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a biopharmaceutical company committed…
The correction refers to the administrative costs for the period January – December 2021 that…
HONG KONG, Mar 25, 2022 – (ACN Newswire) – Kindstar Globalgene Technology, Inc. (“Kindstar Globalgene”…
NEW YORK, Mar 25, 2022 – (ACN Newswire) – Deloitte’s United States Economic Forecast Q1…
HONG KONG, Mar 25, 2022 – (ACN Newswire) – Analogue Holdings Limited (“Analogue” or the…
Companies Will Create New Opportunities in Such Areas as Licensing and Merchandising, Animation, Brand Partnerships,…
– CSI Shareholders Approved Merger Proposal at Special Meeting on March 25, 2022 – CSI…
Positioning Based on Customer Satisfaction, Customer Service Delivery, Growth, Innovation and Digital Banking Capabilities AUSTIN,…
LAS VEGAS–(BUSINESS WIRE)–The Siegel Group Nevada, Inc., a Commercial Real Estate & Development Company, announced…
By Lauren Winans Many employers have been actively reevaluating how they approach human resources, especially…
PALO ALTO, Calif., March 25, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex”), a majority-owned…
International Conference on Alzheimer’s and Parkinson’s Diseases Provides New Insights into the Role of Neuroinflammation…
Polivy plus R-CHP showed first clinically meaningful improvement in PFS with comparable safety in people…
Reported 27-patient dosimetry data from the lead-in cohort of the SPLASH trial Randomization phase of…
CHMP opinion based on Phase III REACH2 and REACH3 trials that showed Jakavi improved response…
Positive opinion paves way for third indication in Europe for Kymriah, a potentially definitive single…
Tapinarof demonstrated continued improvements for up to 52 weeks in efficacy outcomes, quality of life…
BASEL, Switzerland, March 25, 2022 (GLOBE NEWSWIRE) — Noema Pharma, a Swiss-based clinical-stage company targeting…